4//SEC Filing
OncoMed Pharmaceuticals Inc 4
Accession 0001140361-17-015047
CIK 0001302573operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:40 PM ET
Size
6.8 KB
Accession
0001140361-17-015047
Insider Transaction Report
Form 4
Hoey Timothy
SVP, Cancer Biology
Transactions
- Sale
Common Stock
2017-04-04$9.06/sh−5,711$51,731→ 57,225 total - Sale
Common Stock
2017-04-04$8.87/sh−43$381→ 62,936 total
Footnotes (3)
- [F1]Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
- [F2]Includes 12,500 restricted stock units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
- [F3]Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001302573
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 7:40 PM ET
- Size
- 6.8 KB